ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Liver Transplantation in Patients with Portal Vein Thrombosis: Implications and Outcomes

D. Noguchi, C. J. Rosenthal, M. Ha, V. G. Agopian, D. G. Farmer, F. M. Kaldas

Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA

Meeting: 2022 American Transplant Congress

Abstract number: 124

Keywords: Liver transplantation, Portal veins, Risk factors, Survival

Topic: Clinical Science » Liver » 53 - Liver: Cirrhosis - Portal Hypertension and Other Complications

Session Information

Session Name: Cirrhosis: Complications, Portal Hypertension and Renal Management

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 5, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:50pm-6:00pm

Location: Hynes Room 311

*Purpose: Preoperative bland portal vein thrombosis (PVT) is common in Liver transplant (LT) candidates and has been suspected to negatively impact post-LT outcomes, however studies in this area remain lacking. We aimed to investigate the impact of pre-LT PVT on outcomes in high acuity recipients.

*Methods: Patients with and without preoperative PVT were analyzed. PVT patients were sub-divided into two groups (Fig. A): PVT isolated (IPVT) to the main portal vein vs. Extend PVT (EPVT) into the superior mesenteric vein (SMV), splenic vein (SpV) or both SMV and SpV. Demographics, surgical management and post-LT outcomes including PVT recurrence were compared. Patients with malignant tumors were excluded (Retrospective single center, 997 adult-LT patients, January 2012 to March 2020).

*Results: Of 997 patients, median model for end-stage liver disease (MELD) score was 36, and 163 (16%) had preoperative PVT. Post-LT PVT recurred in 20 patients. PVT and no PVT (NPVT) patients had similar post-LT overall survival rates (Patient p=0.34, Graft p=0.45). In 565 patients with a high MELD score ≥35, there was no significant survival difference between PVT and NPVT (Patient p=0.55, Graft p=0.62; Fig. B). Among all PVT patients, 129 had IPVT, and 34 had EPVT and there were no survival differences between NPVT, IPVT and EPVT patients (Fig. C). During portal reconstruction following thromboendovenectomy, 148 patients received end-to-end anastomosis and 15 required a jump graft. In IPVT, end-to-end anastomosis provided better survival outcomes than jump graft (Patient p=0.02, Graft p=0.04). On the other hand, in EPVT, there were no significant differences between these methods of anastomosis (Fig. D). EPVT (OR 3.22, p=0.02) and post-LT bacteremia (OR 3.34, p=0.04) were detected as significant risk factors for PVT recurrence (Fig. E).

*Conclusions: This is the largest single center series examining the impact of pre-LT PVT on post-LT outcomes. Overall, PVT did not impact post-LT outcomes in high acuity patients. However, the results suggest that extensive PVT not amenable to thromboendovenectomy necessitating a jump graft negatively impacts outcomes. Post LT bacteremia was also identified risk factor for PVT recurrence. These findings may aid in perioperative planning and management.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Noguchi D, Rosenthal CJ, Ha M, Agopian VG, Farmer DG, Kaldas FM. Liver Transplantation in Patients with Portal Vein Thrombosis: Implications and Outcomes [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/liver-transplantation-in-patients-with-portal-vein-thrombosis-implications-and-outcomes/. Accessed May 8, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences